81 Publications (Page 1 of 4)
4β‐Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation
Penzak, Scott R and Rojas‐Fernandez, Carlos
The Journal of Clinical Pharmacology, vol. 59, (no. 5), pp. 624, May 2019. | Journal Article
Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy Adults
Yang, JinchengNikanjam, MinaCapparelli, Edmund VTsunoda, Shirley MGreenberg, Howard EPenzak, Scott RStoch, S. AubreyBertino, Joseph SNafziger, Anne N and Ma, Joseph D
The Journal of Clinical Pharmacology, vol. 59, (no. 11), pp. 1504, November 2019. | Journal Article
Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
Jann, Michael and Penzak, Scott
CNS Drugs, vol. 32, (no. 6), pp. 603, 20180600. | Journal Article
Midazolam Single Time Point Concentrations to Estimate Exposure and Cytochrome P450 (CYP) 3A Constitutive Activity Utilizing Limited Sampling Strategy With a Population Pharmacokinetic Approach
Yang, JinchengPatel, MaulikNikanjam, MinaCapparelli, Edmund VTsunoda, Shirley MGreenberg, Howard EPenzak, Scott RAubrey Stoch, SBertino, Joseph SNafziger, Anne N and Ma, Joseph D
The Journal of Clinical Pharmacology, vol. 58, (no. 9), pp. 1213, September 2018. | Journal Article
Potential Influence of Centrally Acting Herbal Drugs on Transporters at the Blood-Cerebrospinal Fluid Barrier and Blood-Brain Barrier.
Kibathi, Lilian WBae, SoHyunPenzak, Scott R and Kumar, Parag
European journal of drug metabolism and pharmacokinetics, June 1, 2018. | Journal Article
Response to “Impact of CYP3A4 Genotype on Voriconazole Exposure: New Insights Into the Contribution of CYP3A422 to Metabolism of Voriconazole”
Walsh, Thomas JMoriyama, BradPenzak, Scott RKlein, Teri E and Caudle, Kelly E
Clinical Pharmacology & Therapeutics, vol. 103, (no. 2), pp. 187, February 2018. | Journal Article
Stability of isoniazid injection in i.v. solutions
Lee, JunMoriyama, BradHenning, StaceyDanner, RobertWalsh, ThomasPenzak, ScottGrimes, George and Potti, Gopal
American Journal of Health-System Pharmacy, vol. 75, (no. 10), pp. 626, 2018-May-15. | Journal Article
The Importance of Authentic Leadership to all Generations Represented within Academic Pharmacy.
Pinelli, Nicole RSease, Julie MNola, KamalaKyle, Jeffrey AHeldenbrand, Seth DPenzak, Scott R and Ginsburg, Diane B
American journal of pharmaceutical education, vol. 82, (no. 6), pp. 6694, August 2018. | Journal Article
Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guideline for CYP2C19 and Voriconazole Therapy
Moriyama, BradMoriyama, BradObeng, Aniwaa OwusuOwusu Obeng, AniwaaBarbarino, JuliaBarbarino, JuliaPenzak, Scott RPenzak, Scott RHenning, Stacey AHenning, Stacey AScott, Stuart AScott, Stuart AAgúndez, José A GAgúndez, José A. GWingard, John RWingard, John RMc Leod, Howard LMcLeod, Howard LKlein, Teri EKlein, Teri ECross, ShaneCross, ShaneCaudle, Kelly ECaudle, Kelly EWalsh, Thomas J and Walsh, Thomas J
Clinical pharmacology and therapeutics, vol. 102, (no. 1), pp. 51, 20170700. | Journal Article
Differential Influence of the Antiretroviral Pharmacokinetic Enhancers Ritonavir and Cobicistat on Intestinal P-Glycoprotein Transport and the Pharmacokinetic/Pharmacodynamic Disposition of Dabigatran
Kumar, ParagGordon, Lori ABrooks, Kristina MGeorge, Jomy MKellogg, AnelaMcManus, MaryellenAlfaro, Raul MNghiem, KhanhLozier, JayHadigan, Colleen and Penzak, Scott R
Antimicrobial agents and chemotherapy, vol. 61, (no. 11), 2017-Nov. | Journal Article
Pharmacokinetic Drug Interactions with Panax ginseng
Ramanathan, MeenakshiRamanathan, MeenakshiPenzak, Scott and Penzak, Scott
European Journal of Drug Metabolism and Pharmacokinetics, vol. 42, (no. 4), pp. 557, 20170800. | Journal Article
Antiretroviral Boosting Agent Cobicistat Increases the Pharmacokinetic Exposure and Anticoagulant Effect of Dabigatran in HIV-Negative Healthy Volunteers
Gordon, LoriKumar, ParagBrooks, KristinaKellogg, AnelaMcManus, MaryellenAlfaro, RaulNghiem, KhanhGeorge, JomyLozier, JayPenzak, Scott and Hadigan, Colleen
Circulation, vol. 134, (no. 23), pp. 1911, 2016-December-6. | Journal Article
Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects.
Calderón, Mónica MPenzak, Scott RPau, Alice KKumar, ParagMcManus, MaryellenAlfaro, Raul M and Kovacs, Joseph A
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 62, (no. 8), pp. 1036-1042, April 15, 2016. | Journal Article
Lack of an Effect of Ritonavir Alone and Lopinavir‐Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers
Gordon, Lori AMalati, Christine YHadigan, ColleenMcLaughlin, MaryAlfaro, Raul MCalderón, Mónica MKovacs, Joseph A and Penzak, Scott R
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 36, (no. 1), pp. 56, January 2016. | Journal Article
Pharmacokinetic Drug Interactions with Panax ginseng.
Ramanathan, Meenakshi R and Penzak, Scott R
European journal of drug metabolism and pharmacokinetics, November 18, 2016. | Journal Article
Part 1 - Coronary angiography with gadofosveset trisodium: a prospective feasibility study evaluating injection techniques for steady-state imaging
Ahlman, Mark ARaman, Fabio SPenzak, Scott RPang, JianingFan, ZhaoyangLiu, SongtaoGai, NevilleLi, Debiao and Bluemke, David A
BMC cardiovascular disorders, vol. 15, (no. 1), pp. 177, 2015-Dec-22. | Journal Article
Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole
Moriyama, BradKadri, SameerHenning, StaceyDanner, RobertWalsh, Thomas and Penzak, Scott
Current Fungal Infection Reports, vol. 9, (no. 2), pp. 87, 20150600. | Journal Article
Emerging drugs and vaccines for candidemia.
Moriyama, BradGordon, Lori AMcCarthy, MatthewHenning, Stacey AWalsh, Thomas J and Penzak, Scott R
Mycoses, vol. 57, (no. 12), pp. 718-733, December 2014. | Journal Article
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.
Ko, Sung-YoulPegu, AmarendraRudicell, Rebecca SYang, Zhi-yongJoyce, M GordonChen, XuejunWang, KeyunBao, SaranKraemer, Thomas DRath, TimoZeng, MingSchmidt, Stephen DTodd, John-PaulPenzak, Scott RSaunders, Kevin ONason, Martha CHaase, Ashley TRao, Srinivas SBlumberg, Richard SMascola, John R and Nabel, Gary J
Nature, vol. 514, (no. 7524), pp. 642-645, October 30, 2014. | Journal Article
HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo.
Hobbs, Charlotte VNeal, JillianConteh, SolomonDonnelly, LiamChen, JingyangMarsh, KennanLambert, LynnOrr-Gonzalez, SachyHinderer, JessicaHealy, SaraBorkowsky, WilliamPenzak, Scott RChakravarty, SumanaHoffman, Stephen L and Duffy, Patrick E
PloS one, vol. 9, (no. 7), pp. e100138, 2014. | Journal Article
Influence of Panax ginseng on the steady state pharmacokinetic profile of lopinavir-ritonavir in healthy volunteers.
Calderón, Mónica MChairez, Cheryl LGordon, Lori AAlfaro, Raul MKovacs, Joseph A and Penzak, Scott R
Pharmacotherapy, vol. 34, (no. 11), pp. 1151-1158, November 2014. | Journal Article
Integrating pharmacogenetic information and clinical decision support into the electronic health record.
Goldspiel, Barry RFlegel, Willy ADiPatrizio, GaryDipatrizio, GarySissung, TristanAdams, Sharon DPenzak, Scott RBiesecker, Leslie GFleisher, Thomas APatel, Jharana JHerion, DavidFigg, William DLertora, Juan J and McKeeby, Jon W
Journal of the American Medical Informatics Association : JAMIA, vol. 21, (no. 3), pp. 522-8, 2014 May-Jun. | Journal Article
Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates.
Hobbs, Charlotte VDixit, SaurabhPenzak, Scott RSahu, TejramOrr-Gonzalez, SachyLambert, LynnZeleski, KatieChen, JingyangNeal, JillianBorkowsky, WilliamWu, Yimin and Duffy, Patrick E
PloS one, vol. 9, (no. 12), pp. e115506, 2014. | Journal Article
Evaluation of partial area under the concentration time curve to estimate midazolam apparent oral clearance for cytochrome P450 3A phenotyping.
Tai, WeiGong, Sheryl LTsunoda, Shirley MGreenberg, Howard EGorski, J CPenzak, Scott RStoch, S A and Ma, Joseph D
Drug metabolism and drug interactions, vol. 28, (no. 4), pp. 217-23, 2013. | Journal Article
Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone.
Boyd, Sarita DHadigan, ColleenMcManus, MaryellenChairez, CherylNieman, Lynnette KPau, Alice KAlfaro, Raul MKovacs, Joseph ACalderon, Monica M and Penzak, Scott R
Journal of acquired immune deficiency syndromes (1999), vol. 63, (no. 3), pp. 355-361, July 1, 2013. | Journal Article